Treatment Technologies & Insights

Treatment Technologies & Insights (TTI) is a health-tech startup that aims to revolutionize healthcare through patient engagement and AI-driven insights. Established in 2016 and headquartered in the United States, TTI focuses on developing patient-reported outcome apps and platforms (ePROs) to enhance health outcomes for individuals with chronic conditions. Their flagship product, Wave Health App, leverages Artificial Intelligence to deliver personalized health insights based on each patient's unique experiences with their chronic condition. Through their ePRO triage system and Wave Health App, TTI facilitates patient self-management and remote monitoring, ultimately minimizing emerging risks, improving quality of life, and enhancing treatment efficacy. Notably, TTI's Wave Health App has been recognized as the #1 mHealth app for tracking patient-reported outcomes in oncology, as validated by a systemic review conducted by Cedars Sinai Medical Center. This accolade underscores TTI's commitment to leveraging technology to make a meaningful impact in the healthcare industry. As TTI continues to make strides in transforming patient care, it remains a compelling prospect for potential venture capital investors seeking opportunities in the health-tech sector. With a clear focus on harnessing AI and patient engagement to drive tangible improvements in healthcare outcomes, TTI's innovative approach positions it as a noteworthy candidate for investment consideration. As the demand for tech-enabled healthcare solutions grows, TTI's endeavors in leveraging AI for personalized patient insights align with the evolving landscape, making it a promising contender in the startup ecosystem. Whether targeting local or global investors, TTI's pioneering efforts in reshaping healthcare through technology merit attention and could present an intriguing investment opportunity. Interested investors can explore TTI's offerings further through their website: https://tti.care/ and https://www.wavehealth.app/.